Chronic lung disease is a vast problem. We’ve made it our problem.
Breathing is Fundamental
500M individuals worldwide suffer from a chronic lung disease
At Vast Therapeutics, we are developing breakthrough medicines to treat chronic respiratory diseases so that patients can get back to shopping with friends. Back to walking the dog. Back to playing with their children or grandchildren. Back to traveling the world.
BACK TO LIVING
Press Releases
Pipeline
Bronchiectasis
Lead Optimization
Preclinical
Phase 1
Phase 2
Phase 3
Cystic Fibrosis
Non-CF Bronchiectasis
Other Respiratory
Lead Optimization
Preclinical
Phase 1
Phase 2
Phase 3
NTM Disease
COPD
Disease Populations
Chronic lung diseases worsen over time due to a harmful cycle of inflammation and infection. This can lead to difficulty breathing, frequent hospital stays, and perpetual decline in quality of life. Our mission is to develop breakthrough therapies that address the root causes of these debilitating conditions and reshape the future of respiratory medicine.
